{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:07:59Z","timestamp":1787969279649,"version":"build-2784847793"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.coviro.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T17:32:58Z","timestamp":1509989578000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Parvovirus B19 infection in pregnancy \u2014 awareness and opportunities"],"prefix":"10.1016","volume":"27","author":[{"given":"Francesca","family":"Bonvicini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Bua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1118-6341","authenticated-orcid":false,"given":"Giorgio","family":"Gallinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2017.10.003_bib0300","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00705-013-1914-1","article-title":"The family Parvoviridae","volume":"159","author":"Cotmore","year":"2014","journal-title":"Arch Virol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"1","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2017.10.003_bib0310","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(81)92739-2","article-title":"Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent","volume":"2","author":"Serjeant","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2017.10.003_bib0315","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0022172400060964","article-title":"An outbreak of erythema infectiosum associated with human parvovirus infection","volume":"93","author":"Anderson","year":"1984","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.coviro.2017.10.003_bib0320","doi-asserted-by":"crossref","DOI":"10.5402\/2013\/898730","article-title":"Parvovirus B19 achievements and challenges","author":"Gallinella","year":"2013","journal-title":"ISRN Virol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/CMR.00040-16","article-title":"Human parvoviruses","volume":"30","author":"Qiu","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coviro.2017.10.003_sbref0330","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S0950268807009661","article-title":"Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection","volume":"136","author":"Mossong","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.coviro.2017.10.003_bib0335","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1128\/JVI.02713-06","article-title":"Biological and immunological relations among human parvovirus B19 genotypes 1 to 3","volume":"81","author":"Ekman","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2017.10.003_sbref0340","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1099\/jmm.0.046714-0","article-title":"The lack of routine surveillance of Parvovirus B19 infection in pregnancy prevents an accurate understanding of this regular cause of fetal loss and the risks posed by occupational exposure","volume":"62","author":"Watt","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0345","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jmv.23757","article-title":"Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women","volume":"86","author":"Barlinn","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0350","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1471-0528.2000.tb13306.x","article-title":"An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors","volume":"107","author":"Jensen","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.coviro.2017.10.003_bib0355","doi-asserted-by":"crossref","first-page":"e92519","DOI":"10.1371\/journal.pone.0092519","article-title":"Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan","volume":"9","author":"Nabae","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2017.10.003_bib0360","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1017\/S0950268814000600","article-title":"The seroprevalence of parvovirus B19 infection in pregnant women in Sudan","volume":"143","author":"Adam","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.coviro.2017.10.003_bib0365","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12884-017-1364-y","article-title":"The magnitude and correlates of Parvovirus B19 infection among pregnant women attending antenatal clinics in Mwanza, Tanzania","volume":"17","author":"Mirambo","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.coviro.2017.10.003_bib0370","first-page":"184","article-title":"Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements","volume":"13","author":"Marano","year":"2015","journal-title":"Blood Transfus"},{"key":"10.1016\/j.coviro.2017.10.003_bib0375","series-title":"Guidance for Industry: Nucleic Acid Testing (NAT) to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products","author":"US Food and Drug Administration","year":"2009"},{"key":"10.1016\/j.coviro.2017.10.003_bib0380","series-title":"European Pharmacopoeia","article-title":"Human plasma (pooled and treated for virus inactivation), monograph 1646","author":"Council of Europe","year":"2008"},{"key":"10.1016\/j.coviro.2017.10.003_bib0385","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0163-4453(98)90346-2","article-title":"The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis","volume":"37","author":"Yaegashi","year":"1998","journal-title":"J Infect"},{"key":"10.1016\/j.coviro.2017.10.003_sbref0390","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JCM.00854-11","article-title":"Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis","volume":"49","author":"Bonvicini","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0395","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/pd.3930","article-title":"Parvovirus B19 in pregnancy: possible consequences of vertical transmission","volume":"32","author":"Puccetti","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.coviro.2017.10.003_bib0400","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.940","article-title":"Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases","volume":"24","author":"Enders","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.coviro.2017.10.003_bib0405","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jcv.2010.07.014","article-title":"Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection","volume":"49","author":"Enders","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhin.2013.12.011","article-title":"Viral infections in pregnancy: advice for healthcare workers","volume":"87","author":"Chin","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.coviro.2017.10.003_bib0415","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2217\/fvl.14.103","article-title":"Human parvovirus B19: a mechanistic overview of infection and DNA replication","volume":"10","author":"Luo","year":"2015","journal-title":"Future Virol"},{"key":"10.1016\/j.coviro.2017.10.003_sbref0420","doi-asserted-by":"crossref","first-page":"e0148547","DOI":"10.1371\/journal.pone.0148547","article-title":"Parvovirus B19 replication and expression in differentiating erythroid progenitor cells","volume":"11","author":"Bua","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2017.10.003_bib0425","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/plac.1998.0353","article-title":"Globoside expression within the human placenta","volume":"20","author":"Jordan","year":"1999","journal-title":"Placenta"},{"key":"10.1016\/j.coviro.2017.10.003_bib0430","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10647440400009912","article-title":"Human parvovirus B19 VP2 empty capsids bind to human villous trophoblast cells in vitro via the globoside receptor","volume":"12","author":"Wegner","year":"2004","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0435","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1128\/JVI.02371-06","article-title":"Hepatitis B virus translocates across a trophoblastic barrier","volume":"81","author":"Bhat","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0440","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tim.2005.02.009","article-title":"Insights into viral transmission at the uterine\u2013placental interface","volume":"13","author":"Pereira","year":"2005","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0445","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcv.2008.10.008","article-title":"Placental endothelial cells can be productively infected by Parvovirus B19","volume":"44","author":"Pasquinelli","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0450","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pd.2714","article-title":"Parvovirus B19 infection in pregnancy: new insights and management","volume":"31","author":"de Jong","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.coviro.2017.10.003_bib0455","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(00)04647-X","article-title":"Frequency of human parvovirus B19 infection in intrauterine fetal death","volume":"357","author":"Tolfvenstam","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2017.10.003_bib0460","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/342575","article-title":"Revised clinical presentation of parvovirus B19-associated intrauterine fetal death","volume":"35","author":"Norbeck","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2017.10.003_bib0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.08.041","article-title":"Fetal thrombocytopenia secondary to parvovirus infection","volume":"196","author":"Segata","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0470","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1471-0528.2007.01555.x","article-title":"Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load","volume":"115","author":"de Haan","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.coviro.2017.10.003_sbref0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.01.048","article-title":"Fetal thrombocytopenia in pregnancies with fetal human parvovirus-B19 infection","volume":"212","author":"Melamed","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.coviro.2017.10.003_sbref0480","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/ije\/dyt117","article-title":"Parvovirus B19 infection in pregnancy and subsequent morbidity and mortality in offspring","volume":"42","author":"Lassen","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0485","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(94)90011-6","article-title":"Congenital anaemia after transplacental B19 parvovirus infection","volume":"343","author":"Brown","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2017.10.003_bib0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/bdra.23588","article-title":"Parvovirus B19 infection during pregnancy and risks to the fetus","volume":"109","author":"Ornoy","year":"2017","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.coviro.2017.10.003_sbref0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.035","article-title":"Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome","volume":"206","author":"De Jong","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0500","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pd.4152","article-title":"Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review","volume":"33","author":"Lindenburg","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.coviro.2017.10.003_bib0505","series-title":"Diagnostic Molecular Pathology","first-page":"103","article-title":"Molecular testing for Parvoviruses","author":"Gallinella","year":"2017"},{"key":"10.1016\/j.coviro.2017.10.003_bib0510","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcv.2005.11.002","article-title":"Human parvovirus B19 infection during pregnancy\u2014value of modern molecular and serological diagnostics","volume":"35","author":"Enders","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0515","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1086\/524302","article-title":"Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops","volume":"197","author":"Enders","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2017.10.003_bib0520","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2011.03.012","article-title":"False-negative serology in patients with acute parvovirus B19 infection","volume":"51","author":"Bredl","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0525","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/infdis\/jir855","article-title":"Serological and virological analysis of maternal and fetal blood samples in prenatal human parvovirus B19 infection","volume":"205","author":"Weiffenbach","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2017.10.003_bib0530","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coviro.2017.10.003_bib0535","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/JCM.01970-13","article-title":"Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay","volume":"51","author":"Bonvicini","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0540","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2015.03.006","article-title":"A new quantitative PCR for human parvovirus B19 genotypes","volume":"218","author":"Toppinen","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.coviro.2017.10.003_bib0545","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1423-0410.2011.01541.x","article-title":"Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays","volume":"102","author":"Baylis","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.coviro.2017.10.003_bib0550","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/cis1046","article-title":"Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus B19 infection: a retrospective study of 10 patients and review of the literature","volume":"56","author":"Crabol","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2017.10.003_bib0555","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2014.11.004","article-title":"Antiviral effect of cidofovir on parvovirus B19 replication","volume":"113","author":"Bonvicini","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.coviro.2017.10.003_bib0560","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virusres.2016.04.002","article-title":"Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells","volume":"220","author":"Bonvicini","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2017.10.003_sbref0565","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcp.2017.03.022","article-title":"Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells","volume":"136","author":"Bonvicini","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coviro.2017.10.003_bib0570","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/1535370216636723","article-title":"Original research: parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era","volume":"241","author":"Hankins","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.coviro.2017.10.003_bib0575","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.vaccine.2011.07.080","article-title":"Safety and immunogenicity of a candidate parvovirus B19 vaccine","volume":"29","author":"Bernstein","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.10.003_bib0580","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1016\/j.vaccine.2013.06.062","article-title":"Generation of a parvovirus B19 vaccine candidate","volume":"31","author":"Chandramouli","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2017.10.003_bib0585","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000362812","article-title":"Intrauterine blood transfusion: current indications and associated risks","volume":"36","author":"Lindenburg","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.coviro.2017.10.003_bib0590","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1515\/JPM.2005.100","article-title":"Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin","volume":"33","author":"Matsuda","year":"2005","journal-title":"J Perinat Med"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625717300834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625717300834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T05:34:29Z","timestamp":1603258469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625717300834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":59,"alternative-id":["S1879625717300834"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2017.10.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parvovirus B19 infection in pregnancy\u2014awareness and opportunities","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}